- Home
- AUPH vs OBK Comparison
AUPH vs OBK Comparison
Compare AUPH & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- OBK
- Stock Information
- Founded
- AUPH 1993
- OBK 1912
- Country
- AUPH Canada
- OBK United States
- Employees
- AUPH N/A
- OBK N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- OBK Major Banks
- Sector
- AUPH Health Care
- OBK Finance
- Exchange
- AUPH Nasdaq
- OBK Nasdaq
- Market Cap
- AUPH 1.1B
- OBK 1.1B
- IPO Year
- AUPH 1999
- OBK 2018
- Fundamental
- Price
- AUPH $8.77
- OBK $35.89
- Analyst Decision
- AUPH Strong Buy
- OBK Buy
- Analyst Count
- AUPH 2
- OBK 5
- Target Price
- AUPH $11.50
- OBK $42.20
- AVG Volume (30 Days)
- AUPH 1.4M
- OBK 167.0K
- Earning Date
- AUPH 07-31-2025
- OBK 07-23-2025
- Dividend Yield
- AUPH N/A
- OBK 1.68%
- EPS Growth
- AUPH N/A
- OBK N/A
- EPS
- AUPH 0.27
- OBK 2.43
- Revenue
- AUPH $247,295,000.00
- OBK $351,348,000.00
- Revenue This Year
- AUPH $12.15
- OBK $13.16
- Revenue Next Year
- AUPH $18.31
- OBK $6.03
- P/E Ratio
- AUPH $31.76
- OBK $14.71
- Revenue Growth
- AUPH 29.20
- OBK 2.92
- 52 Week Low
- AUPH $5.20
- OBK $28.80
- 52 Week High
- AUPH $10.67
- OBK $41.17
- Technical
- Relative Strength Index (RSI)
- AUPH 66.00
- OBK 63.20
- Support Level
- AUPH $7.71
- OBK $35.14
- Resistance Level
- AUPH $8.29
- OBK $36.02
- Average True Range (ATR)
- AUPH 0.25
- OBK 0.67
- MACD
- AUPH 0.03
- OBK 0.08
- Stochastic Oscillator
- AUPH 84.40
- OBK 99.51
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About OBK Origin Bancorp Inc.
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.